Journal article Open Access

Determination and reduction of translocator protein (TSPO) ligand rs6971 discrimination

Sokias, Renee; Werry, Eryn L; Chua, Sook W; Reekie, Tristan A; Munoz, Lenka; Wong, Erik CN; Ittner, Lars M; Kassiou, Michael


JSON-LD (schema.org) Export

{
  "description": "<p>The 18 kDa translocator protein (TSPO) is a target for development of diagnostic imaging agents for glioblastoma and neuroinflammation. Clinical translation of TSPO imaging agents has been hindered by the presence of a polymorphism, rs6971, which causes a non-conservative substitution of alanine for threonine at amino acid residue 147 (TSPO A147T). Disclosed brain-permeant second-generation TSPO ligands bind TSPO A147T with reduced affinity compared to the wild type protein (TSPO WT). Efforts to develop a TSPO ligand that binds TSPO WT and TSPO A147T with similarly high affinity have been hampered by a lack of knowledge about how ligand structure differentially influences interaction with the two forms of TSPO. To gain insight, we have established human embryonic kidney cell lines stably over-expressing human TSPO WT and TSPO A147T, and tested how modifications of a novel <em>N</em>-alkylated carbazole scaffold influence affinity to both TSPO isoforms. Most of the new analogues developed in this study showed high affinity to TSPO WT and a 5\u20136-fold lower affinity to TSPO A147T. Addition of electron-withdrawing substituents yielded analogues with highest affinity for TSPO A147T without decreasing affinity for TSPO WT. This knowledge can be used to inform further development of non-discriminating TSPO ligands for use as diagnostic markers for glioblastoma and neuroinflammation irrespective of rs6971.</p>", 
  "license": "http://creativecommons.org/licenses/by/4.0/legalcode", 
  "creator": [
    {
      "affiliation": "School of Chemistry, The University of Sydney, Australia", 
      "@type": "Person", 
      "name": "Sokias, Renee"
    }, 
    {
      "affiliation": "Faculty of Health Sciences, The University of Sydney, NSW 2006, Australia and School of Medical Sciences (Pharmacology), Bosch Institute, The University of Sydney, NSW 2006, Australia", 
      "@type": "Person", 
      "name": "Werry, Eryn L"
    }, 
    {
      "affiliation": "Dementia Research Unit, School of Medical Sciences, University of New South Wales, NSW 2052, Australia", 
      "@type": "Person", 
      "name": "Chua, Sook W"
    }, 
    {
      "affiliation": "School of Chemistry, The University of Sydney, Australia", 
      "@type": "Person", 
      "name": "Reekie, Tristan A"
    }, 
    {
      "affiliation": "School of Medical Sciences (Pathology) and Charles Perkins Centre, The University of Sydney, NSW 2006, Australia", 
      "@type": "Person", 
      "name": "Munoz, Lenka"
    }, 
    {
      "affiliation": "School of Medical Sciences (Pharmacology), Bosch Institute, The University of Sydney, NSW 2006, Australia", 
      "@type": "Person", 
      "name": "Wong, Erik CN"
    }, 
    {
      "affiliation": "Dementia Research Unit, School of Medical Sciences, University of New South Wales, NSW 2052, Australia", 
      "@type": "Person", 
      "name": "Ittner, Lars M"
    }, 
    {
      "affiliation": "School of Chemistry, The University of Sydney, Australia", 
      "@type": "Person", 
      "name": "Kassiou, Michael"
    }
  ], 
  "url": "https://zenodo.org/record/291817", 
  "image": "https://zenodo.org/static/img/logos/zenodo-gradient-round.svg", 
  "datePublished": "2016-11-15", 
  "headline": "Determination and reduction of translocator protein (TSPO) ligand rs6971 discrimination", 
  "@context": "https://schema.org/", 
  "identifier": "https://doi.org/10.1039/C6MD00523C", 
  "@id": "https://doi.org/10.1039/C6MD00523C", 
  "@type": "ScholarlyArticle", 
  "name": "Determination and reduction of translocator protein (TSPO) ligand rs6971 discrimination"
}
18
13
views
downloads
Views 18
Downloads 13
Data volume 19.0 MB
Unique views 18
Unique downloads 13

Share

Cite as